Glaucoma is one of the leading causes of irreversible blindness worldwide. It is
characterized by progressive optic neuropathy in association with damage to the optic nerve …

Serious vision loss occurs in patients affected by chronically raised intraocular pressure
(IOP), a characteristic of many forms of glaucoma where damage to the optic nerve …

Currently commercial fixed-concomitant three agents have multiple problems such as
multiple dosing administration, poor efficacy and side effects. Once-daily fixed-combination …

In this article, we propose a theoretical model leveraging the analogy between fluid and
electric variables to investigate the relation among aqueous humor (AH) circulation and …

Glaucoma is currently considered one of the leading causes of severe visual impairment
and blindness worldwide. Topical medical therapy represents the treatment of choice for …

Ripasudil–brimonidine fixed-dose combination (K-232) simultaneously targets three
different intraocular pressure (IOP) lowering mechanisms, increasing trabecular meshwork …

Flurbiprofen (FB), a nonsteroidal anti-inflammatory drug, is widely employed in treating
ocular inflammation owing to its remarkable anti-inflammatory effects. However, the racemic …

The prevention of blindness from glaucoma requires multiple treatments to lower intraocular
pressure. Here, human contact lenses are modified with highly porous metal‐organic …

Recent advancements in prostaglandin analogs (PGAs) have reinforced their role in
managing intraocular pressure (IOP). Latanoprost excels in 24-h IOP control, while various …

Glaucoma, leading to progressive partial or complete blindness, is a matter of serious
concern worldwide. Although avoidable with right diagnosis and continuous treatment, a …